{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:10:48Z","timestamp":1791375048927,"version":"4.3.1"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CSL Seqirus Inc., Canada"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Vaccination rates against both influenza and COVID-19 fall short of targets, especially among persons at risk of influenza complications. To gain insights into strategies to boost influenza vaccine coverage, we surveyed 3000 Canadian residents aged \u2265 18 years and examined their knowledge and receipt of co-administered influenza and COVID-19 vaccines. During the 2022\u20132023 influenza season, 70% of respondents reported being aware the influenza and COVID-19 vaccines could be co-administered, but only 26.2% (95% CI, 23.6% to 28.8%) of respondents received them together. The most common reason for not getting the vaccines together was receipt of the COVID-19 vaccine before the annual influenza vaccine was available (reported by 34.5% [31.2% to 37.7%]). Lack of interest in co-administration was reported by 22.6% (20.8% to 24.3%); of this group, 20.8% (17.1% to 24.5%) reported seeing no benefit in receiving the two vaccines together and 17.2% (13.5% to 20.9%) were concerned about compounded adverse effects from the two vaccines. These results support the willingness of most Canadians to receive COVID-19 and influenza vaccines at the same time. Co-administration is a viable strategy to improve uptake of influenza vaccines, especially if health professionals proactively offer education and co-administration of influenza and COVID-19 (or other) vaccines as appropriate to clinical need.<\/jats:p>","DOI":"10.3390\/pharmacy12020070","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:15:20Z","timestamp":1713345320000},"page":"70","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Co-Administration of Influenza and COVID-19 Vaccines: A Cross-Sectional Survey of Canadian Adults\u2019 Knowledge, Attitudes, and Beliefs"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-4357","authenticated-orcid":false,"given":"Sherilyn K. D.","family":"Houle","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Waterloo, ON N2L 3G1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6436-5572","authenticated-orcid":false,"given":"Ajit","family":"Johal","sequence":"additional","affiliation":[{"name":"Travelrx and Immunize.io, Vancouver, BC V5Z 3Y1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roumeliotis","sequence":"additional","affiliation":[{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1N 6N5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Roy","sequence":"additional","affiliation":[{"name":"CSL Seqirus\/Medical Affairs Americas, 16766 TransCanada, Suite 504, Kirkland, QC H9H 4M7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Boivin","sequence":"additional","affiliation":[{"name":"CSL Seqirus\/Medical Affairs Americas, 16766 TransCanada, Suite 504, Kirkland, QC H9H 4M7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"ref_1","unstructured":"Statistics Canada (2023, October 19). Leading Causes of Death, Total Population, by Age Group. Available online: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310039401."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/irv.12521","article-title":"Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network","volume":"12","author":"Ng","year":"2018","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_3","unstructured":"National Advisory Committee on Immunization (2023, June 23). Statement on Seasonal Influenza Vaccine for 2023\u20132024. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-statement-seasonal-influenza-vaccine-2023-2024.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/irv.12963","article-title":"The economic burden of influenza among adults aged 18 to 64: A systematic literature review","volume":"16","author":"Cadarette","year":"2022","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_5","unstructured":"Canadian Institute for Health Information (2023, October 19). National Health Expenditure Trends, 2022\u2014Snapshot. Available online: https:\/\/www.cihi.ca\/en\/national-health-expenditure-trends-2022-snapshot."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s42650-021-00056-w","article-title":"The burden of COVID-19 in Canada","volume":"48","author":"Bignami","year":"2021","journal-title":"Can. Stud. Popul."},{"key":"ref_7","unstructured":"Government of Canada (2024, February 16). COVID-19 Epidemiology Update. Available online: https:\/\/health-infobase.canada.ca\/covid-19\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"Madjid","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e228873","DOI":"10.1001\/jamanetworkopen.2022.8873","article-title":"Association of influenza vaccination with cardiovascular risk: A meta-analysis","volume":"5","author":"Behrouzi","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"key":"ref_11","unstructured":"Government of Canada (2024, February 16). COVID-19 Vaccination: Vaccination Coverage. Available online: https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/."},{"key":"ref_12","unstructured":"Public Health Agency of Canada (2023, October 19). Highlights from the 2022\u20132023 Seasonal Influenza (flu) Vaccination Coverage Survey. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/seasonal-influenza-survey-results-2022-2023.html."},{"key":"ref_13","unstructured":"Public Health Agency of Canada (2023, October 19). Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2022\u20132023. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/canadian-immunization-guide-statement-seasonal-influenza-vaccine-2022-2023.html."},{"key":"ref_14","unstructured":"Public Health Agency of Canada (2023, March 16). Highlights from the 2021\u20132022 Seasonal Influenza (Flu) Vaccination Coverage Survey. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/seasonal-influenza-survey-results-2021-2022.html."},{"key":"ref_15","unstructured":"Public Health Agency of Canada (2023, October 19). COVID-19 Vaccines: Canadian Immunization Guide. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-26-covid-19-vaccine.html."},{"key":"ref_16","unstructured":"Public Health Agency of Canada (2023, October 19). Vaccine Uptake in Canadian Adults 2019. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/2018-2019-influenza-flu-vaccine-coverage-survey-results.html."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Roumeliotis, P., Houle, S.K.D., Johal, A., Roy, B., and Boivin, W. (2023). Knowledge, perceptions, and self-reported rates of influenza immunization among Canadians at high risk from influenza: A cross-sectional survey. Vaccines, 11.","DOI":"10.3390\/vaccines11081378"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Houle, S.K.D., Johal, A., Roumeliotis, P., Roy, B., and Boivin, W. Influenza vaccination in community pharmacy: A cross-sectional survey of Canadian adults\u2019 knowledge, attitudes, and beliefs. Can. Pharm. J., 2024. in press.","DOI":"10.1177\/17151635241240464"},{"key":"ref_19","unstructured":"Statistics Canada (2023, March 10). Census Profile, 2021 Census of Population. Available online: https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/dp-pd\/prof\/index.cfm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.vaccine.2021.11.088","article-title":"Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)","volume":"40","author":"Sulis","year":"2022","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.24095\/hpcdp.43.2.04","article-title":"The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: A repeated, pan-Canadian, cross-sectional study","volume":"43","author":"Cho","year":"2023","journal-title":"Health Promot. Chronic Dis. Prev. Can."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, V., Zhu, P., and Wagner, A.L. (2023). Spillover of vaccine hesitancy into adult COVID-19 and influenza: The role of race, religion, and political affiliation in the United States. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20043376"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14760584.2023.2250437","article-title":"Impact of COVID-19 pandemic on flu vaccine uptake in healthcare workers in Europe: A systematic review and meta-analysis","volume":"22","author":"Bianchi","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1080\/21645515.2020.1735226","article-title":"How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation","volume":"16","author":"Jacobson","year":"2020","journal-title":"Human Vaccines Immunother."},{"key":"ref_25","unstructured":"Immunize Canada (2023, March 16). Influenza Immunization Awareness Campaign. Available online: https:\/\/immunize.ca\/influenza-campaign."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/2\/70\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:29:03Z","timestamp":1760106543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/2\/70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["pharmacy12020070"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy12020070","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}